Tryp Therapeutics Appoints New Chief Operating Officer
- Thursday, June 23, 2022, 7:22
- PR Newswire
- Add a comment
Sid Taubenfeld with Extensive Experience in the Financial Markets and as a Biotech Executive Joins Tryp as Company Prepares to Expand Patient Access to Psilocybin-Based Treatments SAN DIEGO, June 23, 2022 /PRNewswire/ — Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the…
About the Author
admin has written 21043 stories on this site.